HealthEquity Key Executives
This section highlights HealthEquity's key executives, including their titles and compensation details.
Find Contacts at HealthEquity
(Showing 0 of )
HealthEquity Earnings
This section highlights HealthEquity's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Date:
June 02, 2025
Time:
Before Market
Est. EPS:
$0.81
Status:
Unconfirmed
Last Earnings Results
Date:
March 18, 2025
EPS:
$0.69
Est. EPS:
$0.71
Revenue:
$311.82M
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q4 | 2025 | 2025-03-18 | $0.71 | $0.69 |
| Read Transcript | Q3 | 2025 | 2024-12-10 | N/A | N/A |
| Read Transcript | Q2 | 2025 | 2024-09-03 | $0.70 | $0.86 |
| Read Transcript | Q1 | 2025 | 2024-06-03 | $0.66 | $0.80 |
| Read Transcript | Q4 | 2024 | 2024-03-19 | $0.56 | $0.63 |
| Read Transcript | Q3 | 2024 | 2023-12-05 | $0.49 | $0.60 |
| Read Transcript | Q2 | 2024 | 2023-09-05 | $0.47 | $0.53 |
| Read Transcript | Q1 | 2024 | 2023-06-05 | $0.41 | $0.50 |
| Read Transcript | Q4 | 2023 | 2023-03-21 | $0.34 | $0.37 |
| Read Transcript | Q3 | 2023 | 2022-12-07 | N/A | N/A |
| Read Transcript | Q2 | 2023 | 2022-09-07 | N/A | N/A |
| Read Transcript | Q1 | 2023 | 2022-06-06 | $0.28 | $0.27 |
Financial Statements
Access annual & quarterly financial statements for HealthEquity, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | January 31, 2025 | January 31, 2024 | January 31, 2023 | January 31, 2022 | January 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $1.20B | $999.59M | $861.75M | $756.56M | $733.57M |
| Cost of Revenue | $422.51M | $376.95M | $371.66M | $332.85M | $318.24M |
| Gross Profit | $777.26M | $622.64M | $490.09M | $423.71M | $415.33M |
| Gross Profit Ratio | 64.78% | 62.29% | 56.87% | 56.00% | 56.62% |
| Research and Development Expenses | $239.51M | $218.81M | $193.38M | $157.36M | $124.81M |
| General and Administrative Expenses | $132.26M | $103.66M | $95.63M | $84.38M | $84.49M |
| Selling and Marketing Expenses | $90.74M | $79.27M | $68.85M | $58.60M | $49.96M |
| Selling General and Administrative Expenses | $223.00M | $182.93M | $164.48M | $142.98M | $134.46M |
| Other Expenses | $152.41M | $- | $94.59M | $82.79M | $76.06M |
| Operating Expenses | $614.92M | $504.28M | $452.44M | $383.14M | $335.33M |
| Cost and Expenses | $1.04B | $871.45M | $824.10M | $715.99M | $653.57M |
| Interest Income | $13.91M | $12.14M | $1.76M | $1.50M | $1.04M |
| Interest Expense | $60.63M | $55.45M | $48.42M | $36.57M | $34.88M |
| Depreciation and Amortization | $162.45M | $153.08M | $161.20M | $137.19M | $115.90M |
| EBITDA | $339.12M | $282.42M | $171.53M | $102.97M | $154.93M |
| EBITDA Ratio | 28.27% | 28.25% | 19.90% | 13.61% | 21.12% |
| Operating Income | $162.33M | $128.13M | $38.92M | $34.64M | $83.28M |
| Operating Income Ratio | 13.53% | 12.82% | 4.52% | 4.58% | 11.35% |
| Total Other Income Expenses Net | $-46.30M | $-53.09M | $-47.15M | $-42.50M | $-29.87M |
| Income Before Tax | $116.03M | $75.04M | $-38.10M | $-66.74M | $4.14M |
| Income Before Tax Ratio | 9.67% | 7.51% | -4.42% | -8.82% | 0.56% |
| Income Tax Expense | $19.33M | $19.33M | $-11.95M | $-22.45M | $-4.69M |
| Net Income | $96.70M | $55.71M | $-26.14M | $-44.29M | $8.83M |
| Net Income Ratio | 8.06% | 5.57% | -3.03% | -5.85% | 1.20% |
| EPS | $1.11 | $0.65 | $-0.31 | $-0.53 | $0.12 |
| EPS Diluted | $1.09 | $0.64 | $-0.31 | $-0.53 | $0.12 |
| Weighted Average Shares Outstanding | 86.87M | 85.56M | 84.44M | 83.13M | 74.23M |
| Weighted Average Shares Outstanding Diluted | 88.83M | 86.96M | 84.44M | 83.13M | 75.68M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | January 31, 2025 | October 31, 2024 | July 31, 2024 | April 30, 2024 | January 31, 2024 | October 31, 2023 | July 31, 2023 | April 30, 2023 | January 31, 2023 | October 31, 2022 | July 31, 2022 | April 30, 2022 | January 31, 2022 | October 31, 2021 | July 31, 2021 | April 30, 2021 | January 31, 2021 | October 31, 2020 | July 31, 2020 | April 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $311.82M | $300.43M | $299.93M | $287.60M | $262.39M | $249.22M | $243.55M | $244.43M | $233.84M | $216.09M | $206.14M | $205.68M | $203.30M | $179.95M | $189.10M | $184.20M | $188.17M | $179.35M | $176.04M | $190.01M |
| Cost of Revenue | $122.77M | $103.41M | $126.86M | $126.00M | $122.28M | $90.81M | $92.62M | $96.61M | $99.59M | $89.23M | $88.33M | $94.51M | $98.00M | $76.63M | $77.13M | $81.09M | $87.25M | $74.79M | $74.25M | $81.94M |
| Gross Profit | $189.04M | $197.03M | $173.07M | $161.59M | $140.10M | $158.41M | $150.93M | $147.83M | $134.25M | $126.86M | $117.81M | $111.17M | $105.30M | $103.32M | $111.97M | $103.12M | $100.92M | $104.56M | $101.78M | $108.07M |
| Gross Profit Ratio | 60.63% | 65.58% | 57.70% | 56.19% | 53.40% | 63.56% | 61.97% | 60.48% | 57.41% | 58.71% | 57.15% | 54.05% | 51.80% | 57.41% | 59.21% | 55.98% | 53.63% | 58.30% | 57.82% | 56.88% |
| Research and Development Expenses | $64.65M | $60.19M | $58.58M | $56.09M | $55.24M | $55.61M | $54.77M | $53.19M | $52.72M | $48.89M | $46.58M | $45.18M | $45.93M | $38.07M | $37.90M | $35.47M | $32.32M | $30.76M | $30.65M | $31.08M |
| General and Administrative Expenses | $29.98M | $31.79M | $32.26M | $38.24M | $25.29M | $26.38M | $27.09M | $24.89M | $20.83M | $25.13M | $25.94M | $23.73M | $20.88M | $20.00M | $22.81M | $20.69M | $22.90M | $22.10M | $20.49M | $19.00M |
| Selling and Marketing Expenses | $23.08M | $22.64M | $21.52M | $23.49M | $20.56M | $19.66M | $19.12M | $19.93M | $19.20M | $17.25M | $15.84M | $16.56M | $16.32M | $12.73M | $15.48M | $14.09M | $13.46M | $12.88M | $12.17M | $11.46M |
| Selling General and Administrative Expenses | $53.06M | $54.42M | $53.78M | $61.73M | $43.70M | $46.03M | $46.21M | $44.83M | $40.03M | $42.38M | $41.78M | $40.29M | $37.19M | $32.73M | $38.29M | $34.77M | $36.37M | $34.98M | $32.66M | $30.45M |
| Other Expenses | $29.18M | $62.79M | $- | $-477.00K | $128.00K | $3.74M | $272.00K | $23.17M | $23.17M | $23.54M | $24.18M | $23.70M | $-5.77M | $3.12M | $1.48M | $-3.63M | $5.28M | $-421.00K | $-824.00K | $-764.00K |
| Operating Expenses | $146.89M | $177.40M | $112.36M | $117.82M | $98.94M | $124.86M | $124.15M | $121.19M | $115.92M | $114.81M | $112.54M | $109.17M | $106.17M | $90.44M | $96.47M | $90.06M | $87.84M | $84.86M | $82.39M | $80.23M |
| Cost and Expenses | $269.67M | $280.81M | $239.22M | $243.82M | $221.22M | $215.67M | $216.76M | $217.79M | $215.51M | $204.03M | $200.87M | $203.67M | $204.16M | $167.08M | $173.61M | $171.14M | $175.09M | $159.66M | $156.65M | $162.17M |
| Interest Income | $3.03M | $3.90M | $3.10M | $3.88M | $4.34M | $3.71M | $2.48M | $1.60M | $1.18M | $443.00K | $89.00K | $52.00K | $82.00K | $478.00K | $533.00K | $408.00K | $195.00K | $174.00K | $76.00K | $600.00K |
| Interest Expense | $15.26M | $18.16M | $15.43M | $11.79M | $13.64M | $13.54M | $13.27M | $15.00M | $14.30M | $12.16M | $11.49M | $10.46M | $10.75M | $11.88M | $7.25M | $6.69M | $6.77M | $6.95M | $8.89M | $12.26M |
| Depreciation and Amortization | $39.18M | $40.72M | $43.61M | $38.94M | $37.91M | $23.21M | $38.35M | $39.04M | $40.48M | $40.50M | $40.74M | $39.49M | $38.82M | $33.55M | $33.05M | $31.77M | $30.42M | $29.38M | $28.60M | $27.51M |
| EBITDA | $84.40M | $65.09M | $105.65M | $83.97M | $81.27M | $72.41M | $65.84M | $64.05M | $54.79M | $46.48M | $38.36M | $31.90M | $5.80M | $32.30M | $32.52M | $32.39M | $35.85M | $40.46M | $36.80M | $41.81M |
| EBITDA Ratio | 27.07% | 21.67% | 35.23% | 29.20% | 30.97% | 29.06% | 27.03% | 26.20% | 23.43% | 21.51% | 18.61% | 15.51% | 2.85% | 17.95% | 17.20% | 17.58% | 19.05% | 22.56% | 20.91% | 22.01% |
| Operating Income | $42.15M | $19.62M | $60.71M | $43.77M | $41.16M | $30.89M | $24.74M | $23.18M | $19.42M | $12.49M | $5.30M | $1.70M | $-27.25M | $-366.00K | $-875.00K | $4.25M | $146.00K | $11.50M | $9.03M | $15.07M |
| Operating Income Ratio | 13.52% | 6.53% | 20.24% | 15.22% | 15.69% | 12.40% | 10.16% | 9.48% | 8.31% | 5.78% | 2.57% | 0.83% | -13.40% | -0.20% | -0.46% | 2.31% | 0.08% | 6.41% | 5.13% | 7.93% |
| Total Other Income Expenses Net | $-12.19M | $-13.41M | $-14.09M | $-10.53M | $-11.45M | $-9.80M | $-10.52M | $-13.17M | $-13.21M | $-11.72M | $-11.46M | $-10.76M | $-16.52M | $-8.76M | $-6.91M | $-10.32M | $-14.42M | $-7.37M | $-9.72M | $-13.03M |
| Income Before Tax | $29.96M | $6.22M | $46.62M | $33.24M | $29.72M | $21.09M | $14.22M | $10.01M | $8.00K | $-6.18M | $-13.87M | $-18.05M | $-43.77M | $-9.12M | $-7.79M | $-6.07M | $-1.34M | $4.13M | $-691.00K | $2.04M |
| Income Before Tax Ratio | 9.61% | 2.07% | 15.54% | 11.56% | 11.33% | 8.46% | 5.84% | 4.10% | 0.00% | -2.86% | -6.73% | -8.78% | -21.53% | -5.07% | -4.12% | -3.29% | -0.71% | 2.30% | -0.39% | 1.08% |
| Income Tax Expense | $3.60M | $515.00K | $10.79M | $4.43M | $3.35M | $6.41M | $3.64M | $5.92M | $217.00K | $-4.54M | $-3.22M | $-4.41M | $-10.95M | $-4.09M | $-3.97M | $-3.45M | $-6.71M | $2.34M | $-543.00K | $218.00K |
| Net Income | $26.36M | $5.70M | $35.82M | $28.81M | $26.36M | $14.67M | $10.58M | $4.09M | $-209.00K | $-1.64M | $-10.65M | $-13.64M | $-32.82M | $-5.04M | $-3.82M | $-2.62M | $5.37M | $1.79M | $-148.00K | $1.83M |
| Net Income Ratio | 8.46% | 1.90% | 11.94% | 10.02% | 10.05% | 5.89% | 4.34% | 1.67% | -0.09% | -0.76% | -5.17% | -6.63% | -16.14% | -2.80% | -2.02% | -1.42% | 2.85% | 1.00% | -0.08% | 0.96% |
| EPS | $0.30 | $0.07 | $0.41 | $0.33 | $0.31 | $0.17 | $0.12 | $0.05 | $0.00 | $-0.02 | $-0.13 | $-0.16 | $-0.39 | $-0.06 | $-0.05 | $-0.03 | $0.07 | $0.02 | $0.00 | $0.03 |
| EPS Diluted | $0.30 | $0.06 | $0.40 | $0.33 | $0.30 | $0.17 | $0.12 | $0.05 | $0.00 | $-0.02 | $-0.13 | $-0.16 | $-0.39 | $-0.06 | $-0.05 | $-0.03 | $0.07 | $0.02 | $0.00 | $0.03 |
| Weighted Average Shares Outstanding | 86.87M | 87.19M | 87.13M | 86.47M | 85.97M | 85.70M | 85.53M | 85.03M | 84.72M | 84.57M | 81.95M | 84.02M | 83.71M | 83.55M | 83.48M | 81.75M | 76.85M | 76.70M | 72.34M | 70.98M |
| Weighted Average Shares Outstanding Diluted | 88.83M | 88.63M | 88.65M | 88.32M | 87.44M | 87.12M | 86.34M | 86.10M | 84.72M | 84.57M | 84.44M | 84.02M | 83.71M | 83.55M | 83.48M | 81.75M | 78.56M | 77.84M | 72.34M | 72.29M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | January 31, 2025 | January 31, 2024 | January 31, 2023 | January 31, 2022 | January 31, 2021 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $295.95M | $403.98M | $254.27M | $225.41M | $328.80M |
| Short Term Investments | $- | $- | $- | $- | $- |
| Cash and Short Term Investments | $295.95M | $403.98M | $254.27M | $225.41M | $328.80M |
| Net Receivables | $118.01M | $104.89M | $96.83M | $87.43M | $72.77M |
| Inventory | $- | $- | $1 | $- | $- |
| Other Current Assets | $63.80M | $48.56M | $31.79M | $38.49M | $58.61M |
| Total Current Assets | $477.75M | $557.44M | $382.89M | $351.34M | $460.18M |
| Property Plant Equipment Net | $46.42M | $54.39M | $69.32M | $86.98M | $118.61M |
| Goodwill | $1.65B | $1.65B | $1.65B | $1.65B | $1.33B |
| Intangible Assets | $1.20B | $835.95M | $936.36M | $973.14M | $767.00M |
| Goodwill and Intangible Assets | $2.85B | $2.48B | $2.58B | $2.62B | $2.09B |
| Long Term Investments | $- | $- | $- | $- | $- |
| Tax Assets | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $71.57M | $67.87M | $52.18M | $49.81M | $37.42M |
| Total Non-Current Assets | $2.97B | $2.61B | $2.71B | $2.76B | $2.25B |
| Other Assets | $- | $- | $- | $- | $- |
| Total Assets | $3.45B | $3.16B | $3.09B | $3.11B | $2.71B |
| Account Payables | $14.36M | $12.04M | $13.90M | $27.54M | $1.61M |
| Short Term Debt | $10.00M | $9.40M | $37.82M | $33.09M | $90.57M |
| Tax Payables | $- | $- | $- | $- | $- |
| Deferred Revenue | $- | $- | $- | $- | $- |
| Other Current Liabilities | $131.96M | $95.65M | $79.34M | $92.55M | $112.51M |
| Total Current Liabilities | $156.32M | $117.09M | $131.06M | $153.19M | $204.30M |
| Long Term Debt | $84.44M | $923.74M | $1.03B | $1.05B | $1.07B |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $55.83M | $68.67M | $82.67M | $99.85M | $119.73M |
| Other Non-Current Liabilities | $880.72M | $19.27M | $-46.28M | $-51.05M | $-65.42M |
| Total Non-Current Liabilities | $1.02B | $1.01B | $1.06B | $1.10B | $1.13B |
| Other Liabilities | $156.32M | $- | $- | $- | $- |
| Total Liabilities | $1.33B | $1.13B | $1.19B | $1.25B | $1.33B |
| Preferred Stock | $- | $- | $1 | $- | $- |
| Common Stock | $9.00K | $9.00K | $8.00K | $8.00K | $8.00K |
| Retained Earnings | $- | $205.63M | $149.92M | $176.06M | $220.35M |
| Accumulated Other Comprehensive Income Loss | $- | $-0 | $0 | $-0 | $-0 |
| Other Total Stockholders Equity | $2.11B | $1.83B | $1.75B | $1.68B | $1.16B |
| Total Stockholders Equity | $2.11B | $2.04B | $1.90B | $1.85B | $1.38B |
| Total Equity | $2.11B | $2.04B | $1.90B | $1.85B | $1.38B |
| Total Liabilities and Stockholders Equity | $3.45B | $3.16B | $3.09B | $3.11B | $2.71B |
| Minority Interest | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $3.45B | $3.16B | $3.09B | $3.11B | $2.71B |
| Total Investments | $- | $835.95M | $- | $- | $- |
| Total Debt | $52.22M | $933.14M | $994.49M | $1.01B | $1.07B |
| Net Debt | $-243.73M | $529.16M | $740.22M | $782.82M | $746.17M |
Balance Sheet Charts
| Breakdown | January 31, 2025 | October 31, 2024 | July 31, 2024 | April 30, 2024 | January 31, 2024 | October 31, 2023 | July 31, 2023 | April 30, 2023 | January 31, 2023 | October 31, 2022 | July 31, 2022 | April 30, 2022 | January 31, 2022 | October 31, 2021 | July 31, 2021 | April 30, 2021 | January 31, 2021 | October 31, 2020 | July 31, 2020 | April 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $295.95M | $322.16M | $326.89M | $251.23M | $403.98M | $334.06M | $290.35M | $225.64M | $254.27M | $210.20M | $176.89M | $161.25M | $225.41M | $649.13M | $753.75M | $736.77M | $328.80M | $299.36M | $268.91M | $171.09M |
| Short Term Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Cash and Short Term Investments | $295.95M | $322.16M | $326.89M | $251.23M | $403.98M | $334.06M | $290.35M | $225.64M | $254.27M | $210.20M | $176.89M | $161.25M | $225.41M | $649.13M | $753.75M | $736.77M | $328.80M | $299.36M | $268.91M | $171.09M |
| Net Receivables | $118.01M | $106.71M | $108.45M | $106.22M | $104.89M | $96.18M | $92.58M | $98.41M | $96.83M | $87.72M | $90.43M | $86.00M | $87.43M | $84.08M | $74.22M | $74.47M | $72.77M | $64.29M | $70.23M | $69.79M |
| Inventory | $- | $- | $- | $- | $- | $- | $1 | $1 | $1 | $- | $- | $1 | $- | $1 | $- | $1 | $- | $1 | $1 | $- |
| Other Current Assets | $63.80M | $66.37M | $60.28M | $47.45M | $48.56M | $44.17M | $39.63M | $34.35M | $31.79M | $34.25M | $41.27M | $31.67M | $38.49M | $30.92M | $32.64M | $53.87M | $58.61M | $32.38M | $43.98M | $42.90M |
| Total Current Assets | $477.75M | $495.25M | $495.63M | $404.90M | $557.44M | $474.41M | $422.56M | $358.41M | $382.89M | $332.16M | $308.59M | $278.92M | $351.34M | $764.13M | $860.61M | $865.11M | $460.18M | $396.03M | $383.13M | $283.78M |
| Property Plant Equipment Net | $46.42M | $48.73M | $51.08M | $53.19M | $54.39M | $57.99M | $61.12M | $67.26M | $69.32M | $74.16M | $78.62M | $83.60M | $86.98M | $106.08M | $111.15M | $113.62M | $118.61M | $124.09M | $129.62M | $133.38M |
| Goodwill | $1.65B | $1.65B | $1.65B | $1.65B | $1.65B | $1.65B | $1.65B | $1.65B | $1.65B | $1.65B | $1.65B | $1.65B | $1.65B | $1.36B | $1.36B | $1.36B | $1.33B | $1.33B | $1.33B | $1.33B |
| Intangible Assets | $1.20B | $1.23B | $1.25B | $1.07B | $835.95M | $860.51M | $881.94M | $907.70M | $936.36M | $964.53M | $991.95M | $1.01B | $973.14M | $820.95M | $770.33M | $780.79M | $767.00M | $776.31M | $783.11M | $777.48M |
| Goodwill and Intangible Assets | $2.85B | $2.88B | $2.90B | $2.72B | $2.48B | $2.51B | $2.53B | $2.56B | $2.58B | $2.61B | $2.64B | $2.65B | $2.62B | $2.18B | $2.13B | $2.14B | $2.09B | $2.10B | $2.12B | $2.11B |
| Long Term Investments | $- | $- | $- | $- | $-1 | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Tax Assets | $- | $- | $- | $- | $72.71M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $21.00K | $59.00K | $38.00K |
| Other Non-Current Assets | $71.57M | $67.75M | $65.41M | $68.88M | $67.87M | $52.45M | $52.70M | $53.49M | $52.18M | $48.15M | $48.88M | $48.84M | $49.81M | $44.91M | $42.97M | $38.78M | $37.42M | $34.02M | $34.66M | $35.17M |
| Total Non-Current Assets | $2.97B | $2.99B | $3.02B | $2.84B | $2.68B | $2.62B | $2.64B | $2.68B | $2.71B | $2.73B | $2.77B | $2.79B | $2.76B | $2.34B | $2.29B | $2.30B | $2.25B | $2.26B | $2.28B | $2.28B |
| Other Assets | $- | $- | $- | $- | $1 | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $3.45B | $3.49B | $3.51B | $3.25B | $3.24B | $3.09B | $3.07B | $3.04B | $3.09B | $3.06B | $3.07B | $3.07B | $3.11B | $3.10B | $3.15B | $3.16B | $2.71B | $2.66B | $2.66B | $2.56B |
| Account Payables | $14.36M | $10.35M | $10.56M | $18.17M | $12.04M | $13.42M | $12.54M | $13.36M | $13.90M | $15.84M | $15.84M | $13.66M | $27.54M | $5.24M | $4.70M | $9.64M | $1.61M | $6.75M | $11.71M | $7.34M |
| Short Term Debt | $10.00M | $19.90M | $19.79M | $19.51M | $18.81M | $19.54M | $20.05M | $21.29M | $27.66M | $36.74M | $35.67M | $34.55M | $33.09M | $31.95M | $104.23M | $89.85M | $90.57M | $90.29M | $81.73M | $73.30M |
| Tax Payables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Revenue | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-400.00K | $- | $- | $- |
| Other Current Liabilities | $131.96M | $124.29M | $90.56M | $54.54M | $86.24M | $63.28M | $70.68M | $55.00M | $89.50M | $57.79M | $74.00M | $69.44M | $92.55M | $69.88M | $76.20M | $92.81M | $112.51M | $54.33M | $60.34M | $53.97M |
| Total Current Liabilities | $156.32M | $154.54M | $120.91M | $92.22M | $117.09M | $96.24M | $103.27M | $89.66M | $131.06M | $110.38M | $125.52M | $117.65M | $153.19M | $107.07M | $185.12M | $192.30M | $204.30M | $151.36M | $153.78M | $134.60M |
| Long Term Debt | $1.10B | $88.40M | $1.15B | $973.93M | $923.74M | $975.43M | $978.32M | $990.15M | $966.83M | $972.23M | $1.04B | $1.05B | $1.05B | $1.06B | $1.04B | $1.05B | $1.07B | $1.02B | $1.11B | $1.33B |
| Deferred Revenue Non-Current | $- | $- | $- | $48.25M | $48.77M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $55.83M | $58.60M | $63.47M | $63.28M | $141.38M | $66.74M | $74.53M | $81.93M | $82.67M | $89.28M | $92.29M | $95.38M | $99.85M | $110.40M | $115.31M | $124.75M | $119.73M | $123.99M | $129.86M | $134.27M |
| Other Non-Current Liabilities | $22.96M | $907.57M | $25.50M | $19.27M | $19.27M | $-32.87M | $-39.28M | $-45.32M | $12.71M | $9.76M | $-48.90M | $-50.42M | $-51.05M | $-48.88M | $-49.91M | $-57.10M | $-65.42M | $11.43M | $-71.09M | $-78.20M |
| Total Non-Current Liabilities | $1.18B | $1.05B | $1.24B | $1.06B | $1.08B | $1.01B | $1.01B | $1.03B | $1.06B | $1.07B | $1.08B | $1.09B | $1.10B | $1.12B | $1.10B | $1.12B | $1.13B | $1.15B | $1.17B | $1.39B |
| Other Liabilities | $- | $154.54M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $1.33B | $1.36B | $1.36B | $1.15B | $1.20B | $1.11B | $1.12B | $1.12B | $1.19B | $1.18B | $1.21B | $1.21B | $1.25B | $1.23B | $1.29B | $1.31B | $1.33B | $1.30B | $1.32B | $1.52B |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $1 | $- | $0 | $0 | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $9.00K | $9.00K | $9.00K | $9.00K | $9.00K | $9.00K | $9.00K | $9.00K | $8.00K | $8.00K | $8.00K | $8.00K | $8.00K | $8.00K | $8.00K | $8.00K | $8.00K | $8.00K | $8.00K | $7.00K |
| Retained Earnings | $209.27M | $- | $270.26M | $234.44M | $205.63M | $179.26M | $164.59M | $154.01M | $149.92M | $150.12M | $151.77M | $162.42M | $176.06M | $208.88M | $213.91M | $217.73M | $220.35M | $214.98M | $213.19M | $213.34M |
| Accumulated Other Comprehensive Income Loss | $- | $- | $- | $- | $-0 | $0 | $0 | $- | $0 | $- | $-0 | $-0 | $-0 | $-0 | $-0 | $-0 | $-0 | $-27.13M | $-23.40M | $-19.48M |
| Other Total Stockholders Equity | $1.91B | $2.12B | $1.89B | $1.86B | $1.83B | $1.81B | $1.79B | $1.76B | $1.75B | $1.73B | $1.71B | $1.69B | $1.68B | $1.66B | $1.65B | $1.63B | $1.16B | $1.14B | $1.13B | $827.30M |
| Total Stockholders Equity | $2.11B | $2.12B | $2.16B | $2.10B | $2.04B | $1.99B | $1.95B | $1.92B | $1.90B | $1.88B | $1.86B | $1.86B | $1.85B | $1.87B | $1.86B | $1.85B | $1.38B | $1.36B | $1.34B | $1.04B |
| Total Equity | $2.11B | $2.12B | $2.16B | $2.10B | $2.04B | $1.99B | $1.95B | $1.92B | $1.90B | $1.88B | $1.86B | $1.86B | $1.85B | $1.87B | $1.86B | $1.85B | $1.38B | $1.36B | $1.34B | $1.04B |
| Total Liabilities and Stockholders Equity | $3.45B | $3.49B | $3.51B | $3.25B | $3.24B | $3.09B | $3.07B | $3.04B | $3.09B | $3.06B | $3.07B | $3.07B | $3.11B | $3.10B | $3.15B | $3.16B | $2.71B | $2.66B | $2.66B | $2.56B |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $3.45B | $3.49B | $3.51B | $3.25B | $3.24B | $3.09B | $3.07B | $3.04B | $3.09B | $3.06B | $3.07B | $3.07B | $3.11B | $3.10B | $3.15B | $3.16B | $2.71B | $2.66B | $2.66B | $2.56B |
| Total Investments | $- | $- | $- | $- | $-1 | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Debt | $1.11B | $54.15M | $1.16B | $983.68M | $933.14M | $934.62M | $935.98M | $942.17M | $994.49M | $998.25M | $1.00B | $1.01B | $1.01B | $1.01B | $1.06B | $1.06B | $1.07B | $1.09B | $1.10B | $1.31B |
| Net Debt | $812.57M | $-268.01M | $830.56M | $732.45M | $529.16M | $600.56M | $645.63M | $716.53M | $740.22M | $788.05M | $825.11M | $844.36M | $782.82M | $361.46M | $302.87M | $321.14M | $746.17M | $792.26M | $831.50M | $1.14B |
Annual Cash Flow
| Breakdown | January 31, 2025 | January 31, 2024 | January 31, 2023 | January 31, 2022 | January 31, 2021 |
|---|---|---|---|---|---|
| Net Income | $96.70M | $55.71M | $-26.14M | $-44.29M | $8.83M |
| Depreciation and Amortization | $162.45M | $153.08M | $161.20M | $137.19M | $115.90M |
| Deferred Income Tax | $-12.84M | $-13.99M | $-17.18M | $-23.43M | $-5.13M |
| Stock Based Compensation | $96.42M | $77.15M | $62.61M | $52.75M | $42.86M |
| Change in Working Capital | $-6.53M | $-33.13M | $-33.37M | $1.62M | $12.29M |
| Accounts Receivables | $-13.11M | $-8.06M | $-9.57M | $-11.20M | $-413.00K |
| Inventory | $- | $1 | $- | $- | $-30.42M |
| Accounts Payables | $8.89M | $-204.00K | $-26.67M | $-2.18M | $30.42M |
| Other Working Capital | $-2.31M | $-24.87M | $2.87M | $15.01M | $12.71M |
| Other Non Cash Items | $3.64M | $4.01M | $3.53M | $17.15M | $6.86M |
| Net Cash Provided by Operating Activities | $339.86M | $242.83M | $150.65M | $141.00M | $181.62M |
| Investments in Property Plant and Equipment | $-2.08M | $-1.69M | $-119.13M | $-137.08M | $-96.96M |
| Acquisitions Net | $- | $- | $- | $-504.53M | $- |
| Purchases of Investments | $- | $- | $- | $128.17M | $- |
| Sales Maturities of Investments | $- | $- | $- | $2.37M | $- |
| Other Investing Activities | $-503.37M | $-44.38M | $-115.76M | $-128.17M | $-83.87M |
| Net Cash Used for Investing Activities | $-505.45M | $-46.07M | $-119.13M | $-639.25M | $-96.96M |
| Debt Repayment | $175.00M | $-54.38M | $-8.75M | $-65.05M | $-239.06M |
| Common Stock Issued | $- | $- | $- | $456.64M | $286.78M |
| Common Stock Repurchased | $-121.49M | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- | $- |
| Other Financing Activities | $4.06M | $865.00K | $-603.00K | $3.27M | $4.71M |
| Net Cash Used Provided by Financing Activities | $57.57M | $-47.04M | $-2.67M | $394.86M | $52.42M |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $- |
| Net Change in Cash | $-108.03M | $149.71M | $28.85M | $-103.39M | $137.08M |
| Cash at End of Period | $295.95M | $403.98M | $254.27M | $225.41M | $328.80M |
| Cash at Beginning of Period | $403.98M | $254.27M | $225.41M | $328.80M | $191.73M |
| Operating Cash Flow | $339.86M | $242.83M | $150.65M | $141.00M | $181.62M |
| Capital Expenditure | $-2.08M | $-46.07M | $-119.13M | $-137.08M | $-96.96M |
| Free Cash Flow | $337.77M | $196.75M | $31.52M | $3.91M | $84.66M |
Cash Flow Charts
| Breakdown | January 31, 2025 | October 31, 2024 | July 31, 2024 | April 30, 2024 | January 31, 2024 | October 31, 2023 | July 31, 2023 | April 30, 2023 | January 31, 2023 | October 31, 2022 | July 31, 2022 | April 30, 2022 | January 31, 2022 | October 31, 2021 | July 31, 2021 | April 30, 2021 | January 31, 2021 | October 31, 2020 | July 31, 2020 | April 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $26.36M | $5.70M | $35.82M | $28.81M | $26.36M | $14.67M | $10.58M | $4.09M | $-209.00K | $-1.64M | $-10.65M | $-13.64M | $-32.82M | $-5.04M | $-3.82M | $-2.62M | $5.37M | $1.79M | $-148.00K | $1.83M |
| Depreciation and Amortization | $39.18M | $40.72M | $43.61M | $38.94M | $37.91M | $37.78M | $38.35M | $39.04M | $40.48M | $40.50M | $40.74M | $39.49M | $38.82M | $33.55M | $33.05M | $31.77M | $30.42M | $29.38M | $28.60M | $27.51M |
| Deferred Income Tax | $-2.77M | $-4.86M | $184.00K | $-5.39M | $1.93M | $-7.79M | $-7.40M | $-738.00K | $-6.62M | $-3.01M | $-3.09M | $-4.47M | $-14.66M | $-4.71M | $-7.29M | $3.24M | $-4.16M | $-405.00K | $-4.35M | $3.79M |
| Stock Based Compensation | $21.71M | $21.12M | $21.57M | $32.02M | $17.21M | $21.66M | $20.07M | $18.20M | $12.30M | $18.17M | $18.15M | $13.99M | $11.05M | $13.28M | $15.62M | $12.80M | $12.55M | $11.48M | $11.44M | $7.40M |
| Change in Working Capital | $-9.00M | $23.44M | $6.21M | $-29.66M | $-7.05M | $-9.91M | $14.83M | $-31.00M | $8.73M | $-6.90M | $-6.10M | $-29.10M | $35.78M | $-16.83M | $-928.00K | $-16.40M | $15.41M | $8.73M | $16.34M | $-28.18M |
| Accounts Receivables | $-11.29M | $1.74M | $-2.24M | $-1.32M | $-8.71M | $-3.60M | $5.83M | $-1.58M | $-9.12M | $2.71M | $-4.59M | $1.43M | $-1.11M | $-9.86M | $245.00K | $-475.00K | $-8.48M | $8.21M | $-704.00K | $552.00K |
| Inventory | $- | $- | $- | $- | $-2.31M | $6.33M | $-4.02M | $- | $- | $- | $- | $- | $-6.51M | $4.30M | $- | $2.21M | $3.89M | $- | $5.56M | $-9.44M |
| Accounts Payables | $-15.87M | $17.49M | $9.61M | $-2.35M | $2.16M | $-6.33M | $4.02M | $-50.00K | $6.50M | $-7.58M | $-1.53M | $-24.06M | $31.84M | $-3.81M | $-29.83M | $-381.00K | $24.38M | $- | $2.42M | $3.63M |
| Other Working Capital | $18.16M | $4.21M | $-1.16M | $-25.98M | $-496.00K | $-6.31M | $8.99M | $-29.37M | $11.35M | $-2.03M | $17.00K | $-6.47M | $36.89M | $-7.46M | $-1.17M | $-17.75M | $23.89M | $511.00K | $9.07M | $-22.92M |
| Other Non Cash Items | $262.00K | $4.42M | $725.00K | $114.27M | $702.00K | $689.00K | $679.00K | $1.94M | $806.00K | $815.00K | $1.10M | $812.00K | $12.39M | $2.02M | $620.00K | $2.12M | $1.31M | $1.09M | $1.76M | $2.69M |
| Net Cash Provided by Operating Activities | $75.75M | $90.55M | $108.13M | $65.43M | $77.07M | $57.11M | $77.11M | $31.54M | $55.49M | $47.93M | $40.15M | $7.08M | $50.56M | $22.27M | $37.25M | $30.92M | $60.90M | $52.05M | $53.64M | $15.03M |
| Investments in Property Plant and Equipment | $-328.00K | $268.94M | $-741.00K | $-269.95M | $-11.27M | $-15.42M | $-10.25M | $-9.13M | $-10.28M | $-13.53M | $-21.12M | $-74.20M | $-16.30M | $-79.68M | $-22.83M | $-18.27M | $-20.23M | $-21.03M | $-30.40M | $-25.29M |
| Acquisitions Net | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-455.00M | $2.37M | $- | $-49.53M | $- | $- | $- | $- |
| Purchases of Investments | $- | $- | $- | $- | $-3.26M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Sales Maturities of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $2.37M | $- | $2.37M | $- | $- | $- | $- | $- |
| Other Investing Activities | $-13.23M | $-281.80M | $-208.34M | $-269.23M | $3.26M | $-14.88M | $-9.79M | $-9.00M | $-9.88M | $-12.94M | $-19.89M | $-73.05M | $-14.68M | $-2.37M | $2.37M | $-15.78M | $-18.53M | $-18.63M | $-28.93M | $-17.78M |
| Net Cash Used for Investing Activities | $-13.56M | $-12.87M | $-209.08M | $-269.95M | $-11.27M | $-15.42M | $-10.25M | $-9.13M | $-10.28M | $-13.53M | $-21.12M | $-74.20M | $-471.30M | $-79.68M | $-20.47M | $-67.80M | $-20.23M | $-21.03M | $-30.40M | $-25.29M |
| Debt Repayment | $-25.00M | $-25.00M | $175.00M | $50.00M | $- | $- | $- | $-54.38M | $-2.19M | $-2.19M | $-2.19M | $-2.19M | $-74.00K | $-49.35M | $- | $-15.62M | $-15.62M | $-7.81M | $-207.81M | $-7.81M |
| Common Stock Issued | $- | $-4.22M | $1.90M | $2.32M | $3.07M | $2.05M | $438.00K | $- | $6.68M | $- | $2.12M | $2.81M | $-2.00K | $1.06M | $2.48M | $456.64M | $539.00K | $-539.00K | $287.32M | $- |
| Common Stock Repurchased | $-62.98M | $-58.51M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $-426.00K | $-57.41M | $1.62M | $1.77M | $4.12M | $2.03M | $-2.15M | $2.43M | $1.04M | $-588.00K | $-1.20M | $5.15M | $-2.90M | $2.13M | $200.00K | $3.84M | $4.40M | $7.78M | $-4.92M | $-2.55M |
| Net Cash Used Provided by Financing Activities | $-88.41M | $-82.42M | $176.62M | $51.77M | $4.12M | $2.03M | $-2.15M | $-51.03M | $-1.15M | $-1.09M | $-3.39M | $2.96M | $-2.97M | $-47.22M | $200.00K | $444.85M | $-11.22M | $-575.00K | $74.58M | $-10.37M |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $14.92M | $22.14M | $7.94M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Net Change in Cash | $-26.21M | $-4.73M | $75.66M | $-152.75M | $69.92M | $43.72M | $64.70M | $-28.62M | $44.07M | $33.31M | $15.64M | $-64.17M | $-423.71M | $-104.62M | $16.98M | $407.97M | $29.45M | $30.45M | $97.82M | $-20.63M |
| Cash at End of Period | $295.95M | $322.16M | $326.89M | $251.23M | $403.98M | $334.06M | $290.35M | $225.64M | $254.27M | $210.20M | $176.89M | $161.25M | $225.41M | $649.13M | $753.75M | $736.77M | $328.80M | $299.36M | $268.91M | $171.09M |
| Cash at Beginning of Period | $322.16M | $326.89M | $251.23M | $403.98M | $334.06M | $290.35M | $225.64M | $254.27M | $210.20M | $176.89M | $161.25M | $225.41M | $649.13M | $753.75M | $736.77M | $328.80M | $299.36M | $268.91M | $171.09M | $191.73M |
| Operating Cash Flow | $75.75M | $90.55M | $108.13M | $65.43M | $77.07M | $57.11M | $77.11M | $31.54M | $55.49M | $47.93M | $40.15M | $7.08M | $50.56M | $22.27M | $37.25M | $30.92M | $60.90M | $52.05M | $53.64M | $15.03M |
| Capital Expenditure | $-13.56M | $-12.87M | $-209.08M | $-269.95M | $-11.27M | $-15.42M | $-10.25M | $-9.13M | $-10.28M | $-13.53M | $-21.12M | $-74.20M | $-16.30M | $-79.68M | $-22.83M | $-18.27M | $-20.23M | $-21.03M | $-30.40M | $-25.29M |
| Free Cash Flow | $62.19M | $77.69M | $-100.95M | $-204.52M | $65.80M | $41.69M | $66.86M | $22.40M | $45.22M | $34.41M | $19.03M | $-67.13M | $34.26M | $-57.41M | $14.41M | $12.65M | $40.67M | $31.02M | $23.23M | $-10.27M |
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. The company was incorporated in 2002 and is headquartered in Draper, Utah.
Healthcare
Medical - Healthcare Information Services
$86.42
Stock Price
$7.48B
Market Cap
-
Employees
Draper, UT
Location
Revenue (FY 2025)
$1.20B
20.0% YoY
Net Income (FY 2025)
$96.70M
73.6% YoY
EPS (FY 2025)
$1.09
70.3% YoY
Free Cash Flow (FY 2025)
$337.77M
71.7% YoY
Profitability
Gross Margin
64.8%
Net Margin
8.1%
ROE
4.6%
ROA
2.8%
Valuation
P/E Ratio
99.19
P/S Ratio
7.99
EV/EBITDA
27.57
Market Cap
$7.48B
Revenue & Net Income
Profit Margins
Cash Flow Summary
Operating Cash Flow
$339.86M
40.0% YoY
Free Cash Flow
$337.77M
71.7% YoY
Balance Sheet Summary
Total Assets
$3.45B
9.0% YoY
Total Debt
$52.22M
94.4% YoY
Shareholder Equity
$2.11B
2.4% YoY
Dividend Overview
No Dividend Data
HealthEquity, Inc. doesn't currently pay dividends.
HealthEquity Dividends
Explore HealthEquity's dividend history, including dividend yield, payout ratio, and historical payments.
HealthEquity News
Read the latest news about HealthEquity, including recent articles, headlines, and updates.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc (“HealthEquity” or the “Company”) (NASDAQ: HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
USA Today Names HealthEquity to its Top 25 Workplaces
The HSA leader was recognized for its remote-first flexibility and mental health resources, marking its fourth year on the list The HSA leader was recognized for its remote-first flexibility and mental health resources, marking its fourth year on the list
If You Have Suffered Losses in HealthEquity, Inc. (NASDAQ: HQY) You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ: HQY) resulting from allegations that HealthEquity may have issued materially misleading business information to the investing public.
Rosen Law Firm Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY
NEW YORK , April 25, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ: HQY) resulting from allegations that HealthEquity may have issued materially misleading business information to the investing public. So What: If you purchased HealthEquity securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc (“HealthEquity” or the “Company”) (NASDAQ: HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
HQY Announcement: If You Have Suffered Losses in HealthEquity, Inc. (NASDAQ: HQY) You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ: HQY) resulting from allegations that HealthEquity may have issued materially misleading business information to the investing public.
ROSEN, A TOP RANKED LAW FIRM, Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY
NEW YORK , April 23, 2025 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ: HQY) resulting from allegations that HealthEquity may have issued materially misleading business information to the investing public. SO WHAT: If you purchased HealthEquity securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
HealthEquity, Inc. Announcement: If You Have Suffered Losses in HealthEquity, Inc. (NASDAQ: HQY) You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ: HQY) resulting from allegations that HealthEquity may have issued materially misleading business information to the investing public.
ALAR FINAL DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Alarum Technologies Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 15 Deadline in Securities Class Action – ALAR
NEW YORK, April 12, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Alarum Technologies Ltd. (NASDAQ: ALAR) between March 14, 2024 and August 26, 2024, both dates inclusive (the “Class Period”), of the important April 15, 2025 lead plaintiff deadline.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for HQY.